Showing results (1-10 of 103) with videos related to
Sort By:
Pageof 11
Current Drug Discovery Technologies|November 2, 2010
Targeting the nucleus: an overview of Auger-electron radionuclide therapyBart Cornelissen, Katherine A VallisChemical Society Reviews|December 1, 2018
Transition metal compounds as cancer radiosensitizersMartin R Gill, Katherine A VallisInternational Journal of Radiation Biology|March 22, 2016
EGF-coated gold nanoparticles provide an efficient nano-scale delivery system for the molecular radiotherapy of EGFR-positive cancerLei Song, Nadia Falzone, Katherine A VallisInternational Journal of Radiation Oncology, Biology, Physics|February 17, 2012
Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapySamantha Y A Terry, Katherine A VallisMechanisms of Development|September 28, 2002
A high-throughput induction gene trap approach defines C4ST as a target of BMP signalingMichael Klüppel, Katherine A Vallis, Jeffrey L WranaInternational Journal of Radiation Biology|March 20, 2009
Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J softwareZhongli Cai, Katherine A Vallis, Raymond M ReillyNanotheranostics|October 27, 2017
Accumulation of <sup>111</sup>In-Labelled EGF-Au-PEG Nanoparticles in EGFR-Positive Tumours is Enhanced by Coadministration of Targeting LigandLei Song, Sarah Able, Errin Johnson, et al.Therapeutic Delivery|March 6, 2014
Uptake, internalization and nuclear translocation of radioimmunotherapeutic agentsChristopher R T Hillyar, Bart Cornelissen, Katherine A VallisMolecular Cancer Therapeutics|August 22, 2013
Molecular radiotherapy using cleavable radioimmunoconjugates that target EGFR and γH2AXBart Cornelissen, Andrew Waller, Sarah Able, et al.The Lancet. Oncology|July 6, 2017
Targeted radionuclide therapy in combined-modality regimensMartin R Gill, Nadia Falzone, Yong Du, et al.Pageof 11